Andrew Shales

Andrew Shales is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Principal at Zensights LLC since January 2024, focusing on connecting BioPharma Commercial Operations with Best in Class partnerships. Previously, Andrew held the position of Chief Executive Officer at Resilia Pharmaceuticals, Inc. from December 2020 to January 2024, and was a Partner at Peak Pharma Partners from March 2019 to January 2024. Andrew also led Shales & Associates, a consulting firm specializing in commercial solutions for start-ups and small to medium-sized pharma/biotech companies, from October 2007 to December 2023. Andrew's extensive experience includes roles such as General Manager at Galen US Inc., Senior Director of Marketing at Exact Sciences, and Senior Vice President of Sales & Marketing at Auriga Laboratories and Synthon Laboratories. Andrew's educational background includes a Master of Science in Pharmaceutical & Medical Device Law & Compliance from Seton Hall University School of Law, expected to complete in June 2025, and a Bachelor of Arts in Psychology from King’s College.